These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 23769558

  • 1. Hypermethylation of testis derived transcript gene promoter significantly correlates with worse outcomes in glioblastoma patients.
    Wang LJ, Bai Y, Bao ZS, Chen Y, Yan ZH, Zhang W, Zhang QG.
    Chin Med J (Engl); 2013; 126(11):2062-6. PubMed ID: 23769558
    [Abstract] [Full Text] [Related]

  • 2. Downregulation of TES by hypermethylation in glioblastoma reduces cell apoptosis and predicts poor clinical outcome.
    Bai Y, Zhang QG, Wang XH.
    Eur J Med Res; 2014 Dec 11; 19(1):66. PubMed ID: 25498217
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A distinct region of the MGMT CpG island critical for transcriptional regulation is preferentially methylated in glioblastoma cells and xenografts.
    Malley DS, Hamoudi RA, Kocialkowski S, Pearson DM, Collins VP, Ichimura K.
    Acta Neuropathol; 2011 May 11; 121(5):651-61. PubMed ID: 21287394
    [Abstract] [Full Text] [Related]

  • 9. Status of O⁶ -methylguanine-DNA methyltransferase [MGMT] gene promoter methylation among patients with glioblastomas from India.
    Nehru GA, Pai R, Samuel P, Chacko AG, Chacko G.
    Neurol India; 2012 May 11; 60(5):481-6. PubMed ID: 23135024
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Promoter methylation and silencing of the tissue factor pathway inhibitor-2 (TFPI-2), a gene encoding an inhibitor of matrix metalloproteinases in human glioma cells.
    Konduri SD, Srivenugopal KS, Yanamandra N, Dinh DH, Olivero WC, Gujrati M, Foster DC, Kisiel W, Ali-Osman F, Kondraganti S, Lakka SS, Rao JS.
    Oncogene; 2003 Jul 17; 22(29):4509-16. PubMed ID: 12881707
    [Abstract] [Full Text] [Related]

  • 12. Methylation Status of the RIZ1 Gene Promoter in Human Glioma Tissues and Cell Lines.
    Zhang C, Meng W, Wang J, Lu Y, Hu G, Hu L, Ma J.
    Cell Mol Neurobiol; 2017 Aug 17; 37(6):1021-1027. PubMed ID: 27757741
    [Abstract] [Full Text] [Related]

  • 13. Relevance of MSP assay for the detection of MGMT promoter hypermethylation in glioblastomas.
    Yachi K, Watanabe T, Ohta T, Fukushima T, Yoshino A, Ogino A, Katayama Y, Nagase H.
    Int J Oncol; 2008 Sep 17; 33(3):469-75. PubMed ID: 18695875
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prognostic impact of O6-methylguanine-DNA methyltransferase silencing in patients with recurrent glioblastoma multiforme who undergo surgery and carmustine wafer implantation: a prospective patient cohort.
    Metellus P, Coulibaly B, Nanni I, Fina F, Eudes N, Giorgi R, Barrie M, Chinot O, Fuentes S, Dufour H, Ouafik L, Figarella-Branger D.
    Cancer; 2009 Oct 15; 115(20):4783-94. PubMed ID: 19637364
    [Abstract] [Full Text] [Related]

  • 18. Methylation of O6-methylguanine DNA methyltransferase and loss of heterozygosity on 19q and/or 17p are overlapping features of secondary glioblastomas with prolonged survival.
    Eoli M, Menghi F, Bruzzone MG, De Simone T, Valletta L, Pollo B, Bissola L, Silvani A, Bianchessi D, D'Incerti L, Filippini G, Broggi G, Boiardi A, Finocchiaro G.
    Clin Cancer Res; 2007 May 01; 13(9):2606-13. PubMed ID: 17473190
    [Abstract] [Full Text] [Related]

  • 19. Methylome analysis and integrative profiling of human HCCs identify novel protumorigenic factors.
    Neumann O, Kesselmeier M, Geffers R, Pellegrino R, Radlwimmer B, Hoffmann K, Ehemann V, Schemmer P, Schirmacher P, Lorenzo Bermejo J, Longerich T.
    Hepatology; 2012 Nov 01; 56(5):1817-27. PubMed ID: 22689435
    [Abstract] [Full Text] [Related]

  • 20. Prognostic significance of molecular markers and extent of resection in primary glioblastoma patients.
    Felsberg J, Rapp M, Loeser S, Fimmers R, Stummer W, Goeppert M, Steiger HJ, Friedensdorf B, Reifenberger G, Sabel MC.
    Clin Cancer Res; 2009 Nov 01; 15(21):6683-93. PubMed ID: 19861461
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.